Control group | Day 1 group | Day 2 group | Day 7 group | p value | |
---|---|---|---|---|---|
n = 7 | n = 7 | n = 7 | n = 7 | ||
Lung | |||||
Interstitial edema | 0 (0 – 1) | 1 (1 – 2) | 1 (1 – 2) | 2 (2 – 3) | <0,001 |
Hemorrhage | 1 (0 – 1) | 2 (2 – 2) | 2 (2 – 2) | 3 (2 – 3) | <0,001 |
Epithelial injury | 0 (0 – 1) | 1 (1 – 2) | 1 (1 – 2) | 2 (1 – 2) | <0,001 |
Hyalin membrane formation | 0 (0 – 0) | 1 (1 – 1) | 1 (1 – 2) | 2 (1 – 2) | <0,001 |
Neutrophil infiltration | 0 (0 – 1) | 2 (1 – 2) | 2 (1 – 2) | 2 (2 – 3) | <0,001 |
Emphysematous changes | 0 (0 – 1) | 1 (1 – 2) | 2 (1 – 2) | 2 (2 – 3) | <0,001 |
Lymphocytic infiltration | 1 (0 – 1) | 1 (1 – 2) | 2 (1 – 2) | 2 (1 – 2) | 0,017 |
Total injury score | 2 (1 – 4) | 9 (8 – 13) | 11 (9 – 13) | 15 (11 – 18) | <0,001 |
Heart | |||||
Myocardial edema | 0 (0 – 0) | 1 (1 – 2) | 1 (1 – 2) | 2 (2 – 2) | <0,001 |
Myocytolysis | 0 (0 – 1) | 1 (1 – 2) | 2 (1 – 2) | 3 (3 – 3) | <0,001 |
Focal hemorrhage | 0 (0 – 1) | 1 (1 – 2) | 2 (1 – 2) | 3 (3 – 3) | <0,001 |
Leukocytic infiltration | 0 (0 – 0) | 1 (0 – 2) | 1 (1 – 2) | 2 (1 – 2) | <0,001 |
Loss of cross striation | 0 (0 – 0) | 1 (1 – 1) | 1 (1 – 1) | 2 (1 – 2) | <0,001 |
Total injury score | 0 (0 – 2) | 5 (4 – 9) | 7 (6 – 8) | 11 (10 – 12) | <0,001 |